Come up with a name for your new list and we'll add to it:
Melinta Therapeutics raised a round of funding on February 10, 2014. Investors include
Vatera Healthcare Partners.
Melinta Therapeutics, formerly Rib-X Pharmaceuticals, is dedicated to the discovery, development and commercialization of groundbreaking antibiotics to overcome drug-resistant, life-threatening infect…